About this journal

Aims and scope

The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal.

The journal provides the international community with a platform for the dissemination and study of clinical, translational, and basic research findings in this rapidly developing field. Primary liver tumors, primarily hepatocellular carcinoma (HCC), are the third leading cause of cancer death worldwide, with around 750,000 new cases annually, and around 700,000 deaths. While 80% occurs in the developing world, the incidence is beginning to decline due to hepatitis B vaccination and developments in food hygiene; conversely, there is an increasing incidence in the developed world, partly due to metabolic syndrome, obesity and diabetes.

The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.

Meta-analyses will no longer be considered for publication.

Specific topics covered by the journal include:

  • cell signalling pathways
  • molecular tumor classification and prognostication
  • new drugs and other therapies
  • new radiology approaches
  • epidemiology, surveillance, and prevention
  • psychosocial aspects and quality of life issues

The journal will consider case reports only if they make a valuable and original contribution to the literature. Study protocols are not suitable unless at least pilot or baseline data are provided.

When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors' own data through replication in an original sample.

Journal metrics

Usage

  • 63K annual downloads/views

Citation metrics

  • 4.2 (2023) Impact Factor
  • Q2 Impact Factor Best Quartile
  • 4.1 (2023) 5 year IF
  • 0.5 (2023) CiteScore (Scopus)
  • 0.000 (2023) SNIP
  • 0.000 (2023) SJR

Editorial board

Editor-in-Chief:

Prof. Dr. Ahmed O Kaseb, Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, United States


Associate Editors-in-Chief:

Dr Rony Avritscher, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Dr Laura A. Dawson, Department of Radiation Oncology, University of Toronto, Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Professor Khaled Elsayes, Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, United States

Dr David Gerber, Christian R. Holmes Professor of Surgery and Chair, Department of Surgery, University of Cincinnati, Cincinnati, OH, USA

Dr Mannal M. Hassan, Department of Epidemiology, University of Texas, MD Anderson Cancer Center, United States

Dr Ali Hosni, Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Canada 

Prof. Dr. Mohamed K Shaker, Tropical Medicine and Hepatology, Ain Shams University, Egypt

Dr Hop Tran Cao, Surgical Oncology, The University of Texas MD Anderson Cancer Center, United States 

Professor Jorg Trojan, Department of Medicine, University Hospital Frankfurt, Germany

Professor Imam Waked, Department of Hepatology, National Liver Institute, Menofia University, Egypt


Editorial Board:

Professor Stephen J Beebe, Frank Reidy Research Center for Bioelectric, Old Dominion University, United States

Dr Srikanta Dash, Pathology and Laboratory Medicine, Tulane University Health Sciences Center, New Orleans, LA, United States

Dr Aldo Dettino, Clinical Oncology, A. C. Camargo Cancer Center, Brazil

Dr Dan Duda, Department of Radiation Oncology, Harvard Medical School, Charlestown, MA, United States

Professor Mahmoud El Meteini, Professor, Faculty of Medicine - Ain Shams University, Egypt. 

Professor Tamer Elbaz, Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University, Egypt

Dr Hesham Elghazaly, Oncology, Ain Shams University, Cairo, Egypt

Dr Catherine Frenette, Division of Gastroenterology and Hepatology, Scripps Green Hospital, United States

Professor Asmaa Gomaa, Hepatology, National Liver Institute, Menofia University, Egypt

Dr Heping Hu, Department of Hepatobilliary Medicine, Eastern Hepatobiliary Hospital, China Mainland (PRC)

Prof. Dr. Do Young Kim, Internal Medicine, Yonsei University College of Medicine, Korea, Republic of (South)

Professor Philippe Merle, Hepato-Gastroenterology and Digestive Oncology, and Epigenetics and Epigenomics of Hepatocellular Carcinoma (EpiHep), Centre of Research in Cancerology, Lyon University and Croix-Rousse Hospital, Lyon, France

Dr Ganesh Nagarajan, Consultant Surgeon Hepatobiliary Pancreatic, GI oncology & Liver Transplant, P D Hinduja Hospital, Mumbai, India

Prof. Dr. Ashraf Omar, Hepatology & Liver Transplantation, Consultant Founder of multidisciplinary HCC clinic Cairo University, President of Egyptian society of liver Cancer, Head of MENA NCCN Committee for HCC, Board member of Africa HepatoPancreatoBiliary Cancer Consortium (AHPBCC), Board member of Society of liver Diseases in Africa (SOLDA), Egypt

Dr Tushar Patel, Medicine, Mayo Clinic College of Medicine, Jacksonville, FL, USA

Dr Ramavath, Department of Pediatrics at the Washington University, USA

Professor Lorenza Rimassa, Associate Professor of Medical Oncology, Director of the Residency Program in Medical Oncology, Department of Biomedical Sciences, Humanitas University, Head of Hepatopancreatobiliary Oncology, Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy

Professor Rodolfo Sacco, Department of Gastroenterology, University of Foggia, Italy

Professor Toshihito Seki, Liver disease center, Kansai Medical University Medical Center, Japan

Professor Ming Shi, Department of Hepatobiliary Oncology, Sun Yat-sen University, China Mainland (PRC)

Prof. Dr. Oliver Stoeltzing, Head Doctor, Zentrum für Allgemein- und Viszeralchirurgie Riesa-Meißen, Elblandkliniken, Meißen, Germany

Dr Janio Szklaruk, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, United States

Professor Hua Tang, Molecular Biology & Microbiology, School of Basic Medical Sciences, Tianjin Medical University, China Mainland (PRC)

Dr Harrys A Torres, Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, United States

Professor Jia-Sheng Wang, Department of Environmental Health Science, College of Public Health, University of Georgia, United States

Professor Chia Jui Weng, Department of Food Science and Biotechnology, National Chung Hsing University, Taichung, Taiwan

Abstracting and indexing

Journal of Hepatocellular Carcinoma is indexed/tracked/covered by the following services:

Current Contents®/Life Sciences

Directory of Open Access Journals (DOAJ)

EMBASE (Elsevier)

Journal Citation Reports/Science Edition

Pubmed (NLM)

PubMed Central Selective Deposit Medicine & Health (NLM)

Science Citation Index Expanded (Clarivate Analytics)

Scopus (Elsevier)

Open access

Journal of Hepatocellular Carcinoma is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.

Use our APC finder to calculate your article publishing charge

News, offers and calls for papers

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors